ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0230148 | The area in the front part of the chest between the lungs. | Structure of anterior mediastinum (body structure)|anterior mediastinum|prevascular space|Mediastinum anterius|Anterior mediastinum|Anterior Mediastinum|MEDIASTINUM, ANTERIOR|Structure of anterior mediastinum|Anterior mediastinal part of chest | Anterior mediastinum |
C1280191 | null | Entire azygos vein|Entire azygous vein|Entire azygous vein (body structure) | Entire azygous vein |
C0226042 | null | Entire right coronary artery|Entire RCA - Right coronary artery|Entire right coronary artery (body structure) | Entire right coronary artery |
C0225897 | The left lower chamber of the heart that receives blood from the left atrium and pumps it through the aorta to the body. | Left cardiac ventricular structure|Left Ventricle|Left cardiac ventricular structure (body structure)|Ventricles, Left|Ventriculus cordis sinister|Left Ventricles|Ventricle, Left|Left ventricle, NOS|Left ventricular structure|Left ventricle|HEART, LEFT VENTRICLE|Heart--Left ventricle|left ventricle|LEFT VENTRICLE|Ventriculus sinister|Left ventricle of heart | Left ventricular structure |
C1335434 | A benign adipose tissue neoplasm of the pleural cavity. It may be purely intra-thoracic or extend to the chest wall. | Lipoma of Pleura|Pleural lipoma|Pleural Lipoma|Lipoma of pleura (disorder)|Lipoma of the Pleura | Lipoma of pleura |
C0750865 | an abnormal condition where adjacent structures or parts are joined by a broad band of tissue | Webbing|Web|webbing | Webbing |
C0253356 | null | null | 2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid |
C0253356 | null | null | 2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid |
C0253356 | null | null | 2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid |
C0253356 | null | null | 2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid |
C0253356 | null | null | 2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid |
C0253356 | null | null | 2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid |
C0814942 | A Chinese person from the Han ethnic group (including Chuanqing). | HAN|Han Chinese|HA | Han Chinese |
C0543698 | null | hypersensitivity diseases|Hypersensitivity disease|hypersensitivity syndrome|Hypersensitivity Diseases|syndrome hypersensitive | hypersensitive syndrome |
C0014518 | A systemic, serious, and life-threatening disorder characterized by erythematous and necrotic lesions in the skin and mucous membranes that are associated with bullous detachment of the epidermis. The epidermal and mucous membranes detachment leads to sepsis and may be fatal. The lesions appear throughout the body and occupy more than 30% of the body surfaces. It is a hypersensitivity reaction usually caused by drugs (e.g., sulfonamides, nonsteroidal anti-inflammatory drugs, anticonvulsants, and antiretroviral drugs). | LYELL'S SYNDROME|Toxic Epidermal Necrolyses|toxic epidermal necrolysis|Epidermal Necrolyses, Toxic|Lyell's toxic epidermal necrolysis, subepidermal type|Necrolysis, Toxic Epidermal|Lyell's Syndrome|Syndromes, Lyell's|Lyell's syndrome|lyell's syndrome|NECROLYSIS, TOXIC EPIDERMAL|Necrolyses, Toxic Epidermal|Toxic epidermal necrolysis (disorder)|SYNDROME LYELL'S|lyell syndrome|Lyell Syndrome|Toxic Epidermal Necrolysis|TOXIC EPIDEONEAL NECROLYSIS|Epidermal Necrolysis, Toxic|LYELL SYNDROME|Scalded Skin Syndrome, Nonstaphylococcal|Syndrome, Lyell's|lyell|Nonstaphylococcal Scalded Skin Syndrome|Lyell's Syndromes|TEN|Lyell syndrome (disorder)|EPIDERMOLYSIS, ACUTE TOXIC|Lyell syndrome|lyells syndrome|TENS|toxic epidermal necrolyses|lyells|Toxic epidermal necrolysis | Toxic Epidermal Necrolysis |
C0440519 | null | B*1502 (substance) | B*1502 |
C0085217 | A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. | Lithium carbonate|lithium carbonate|Carbonate, Lithium|of lithium carbonate|Lithium carbonate (substance)|Carbonate, Dilithium|Lithii carbonas|Product containing lithium carbonate (medicinal product)|LITHIUM CARBONATE|Dilithium Carbonate|carbonate lithium|Dilithium carbonate|Carbonic acid, dilithium salt|Lithium carbonate preparation|Lithium Carbonate|Lithium carbonate-containing product | lithium carbonate |
C0003123 | The lack or loss of APPETITE accompanied by an aversion to food and the inability to eat. It is the defining characteristic of the disorder ANOREXIA NERVOSA. | lack of appetite|anorexic|loss of appetite|Anorexias|Anorexia|lost appetite|no appetite|anorexia (loss of appetite)|anorexia|anorectic|Anorexic|appetite loss|ANOREXIA | Anorexia |
C0006370 | Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as "ox hunger". | Bulimia|Binge Eating|Bulimias|Binge and purge|bulimia|BULIMIA|Eating, Binge | Bulimia |
C0039474 | Predisposition to react to one's environment in a certain way; usually refers to mood changes. | temperament|Temperaments|Temperament | Temperament |
C1412099 | This gene is involved in blood group determination. | TRANSFERASE A, ALPHA 1-3-N-ACETYLGALACTOSAMINYLTRANSFERASE|A3GALT1|ABO gene|TRANSFERASE B, ALPHA 1-3-GALACTOSYLTRANSFERASE|A3GALNT|ABO GLYCOSYLTRANSFERASE|ABO HISTO-BLOOD GROUP GLYCOSYLTRANSFERASES|ABO|ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase|ABO Gene|ABO Blood Group (Transferase A, Alpha 1-3-N-Acetylgalactosaminyltransferase; Transferase B, Alpha 1-3-Galactosyltransferase) Gene | ABO gene |
C1412099 | This gene is involved in blood group determination. | TRANSFERASE A, ALPHA 1-3-N-ACETYLGALACTOSAMINYLTRANSFERASE|A3GALT1|ABO gene|TRANSFERASE B, ALPHA 1-3-GALACTOSYLTRANSFERASE|A3GALNT|ABO GLYCOSYLTRANSFERASE|ABO HISTO-BLOOD GROUP GLYCOSYLTRANSFERASES|ABO|ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase|ABO Gene|ABO Blood Group (Transferase A, Alpha 1-3-N-Acetylgalactosaminyltransferase; Transferase B, Alpha 1-3-Galactosyltransferase) Gene | ABO gene |
C0282402 | Therapeutic use of hormones to alleviate the effects of hormone deficiency. | hormone replacement|hormone replacements|menopausal hormone therapy|hormone replacement therapy (HRT)|HRT (hormone replacement therapy)|Hormone Replacement Therapy|Replacement Therapy, Hormone|Hormone replacement therapy|Hormone Replacement Therapies|HRT|therapy, hormone replacement|Menopausal Hormone Therapy|hormone replacement therapies|Hormone replacement therapy (procedure)|Hormone Replacement Rx|therapy, replacement|Menopausal hormone therapy|Therapies, Hormone Replacement|Therapy, Hormone Replacement|hormones replacement|HRT - Hormone replacement therapy|Replacement Therapies, Hormone|ERT|replacement therapy|hormone replacement therapy | Hormone replacement therapy |
C0392334 | null | Cognitive ability|abilities cognitive|intellectual functioning|cognitive ability|Ability to perform cognitive activity (observable entity)|function intellectual|ability cognitive|cognitive functioning|Ability to perform cognitive activity | Ability to perform cognitive activity |
C1513016 | Compounds that inhibit the enzyme activity or activation of MATRIX METALLOPROTEINASES. | MMP Inhibitors|Metalloproteinase Inhibitors, Matrix|Inhibitors, Matrix Metalloproteinase|Inhibitors, MMP|Matrix Metalloproteinase Inhibitor|MMP Inhibitor | Matrix Metalloproteinase Inhibitors |
C0025932 | Mutant mice homozygous for the recessive gene "nude" which fail to develop a thymus. They are useful in tumor studies and studies on immune responses. | Nude Mouse|Nude|Nude mouse|Athymic Mice|nude mouse|Nude Mice|athymic mouse|NU|Athymic Mouse|Mouse, Nude|Mice, Nude|mice nude|Mouse, Athymic|Mice, Athymic|athymic, nude mouse|Athymic Nude Mouse|nu/nu|nude mice | Mice, Nude |
C0165519 | An endopeptidase that is structurally similar to MATRIX METALLOPROTEINASE 2. It degrades GELATIN types I and V; COLLAGEN TYPE IV; and COLLAGEN TYPE V. | Matrix Metalloproteinase-9|92 kDa Type IV Collagenase|Matrix metalloproteinase 9|MMP 9 Metalloproteinase|MMP-9|Matrix Metalloprotease-9|mmp-9|92-kd gelatinase|Metalloproteinase, MMP-9|Type V Collagenase|MMP9|Gelatinase B (substance)|Metalloproteinase, MMP9|Matrix Metalloprotease 9|EC 3.4.24.35|Metalloproteinase 9, Matrix|92 kDa Gelatinase|MMP9 Metalloproteinase|Matrix Metalloproteinase 9|92-kDa Type IV Collagenase|MMP-9 Metalloproteinase|Gelatinase B|GELB|92-kDa Gelatinase|9 matrix metalloproteinase|Macrophage Gelatinase | Matrix Metalloproteinase 9 |
C0302592 | Cancer that forms in tissues of the cervix (the organ connecting the uterus and vagina). It is usually a slow-growing cancer that may not have symptoms but can be found with regular Pap tests (a procedure in which cells are scraped from the cervix and looked at under a microscope). Cervical cancer is almost always caused by human papillomavirus (HPV) infection. | carcinoma cervix uterine|Cancer of the Uterine Cervix|Cervical Cancer|Carcinoma of the Cervix|Cancer of Uterine Cervix|CARCINOMA OF CERVIX|cervical carcinoma|Cervical cancer, NOS|Carcinoma of Cervix|Cervix Cancer|CARCINOMA OF CERVIX <INVASIVE>|Cervix Carcinoma|Cervix Uteri Carcinoma|Carcinoma of Cervix Uteri|UTERINE CERVIX, CARCINOMA|COLLUM CARCINOMA|Carcinoma of cervix|CARCINOMA UTERINE CERIX|Uterine Cervix Carcinoma|CERVIX CARCINOMA|Carcinoma of the Uterine Cervix|Cervical carcinoma|carcinoma cervix|cervical cancer|CERVICAL CANCER|Carcinoma of Uterine Cervix|Cancer of the Cervix|Carcinoma of the Cervix Uteri|cervix carcinoma|CARCINOMA OF CERVIX INVASIVE|Cancer of Cervix|CARCINOMA CERVIX|Cervical Carcinoma|Uterine Cervix Cancer|CERVICAL CARCINOMA|carcinoma cervical|Carcinoma of cervix (disorder)|carcinoma of cervix | Cervix carcinoma |
C0111429 | A 50-kDa protein that complexes with CYCLIN-DEPENDENT KINASE 2 in the late G1 phase of the cell cycle. | Cyclin E|Cyclin-E|CCNE|cyclin e|G1/S-Specific Cyclin-E | Cyclin E |
C0150094 | Sample in which the units are chosen on a strict "first come - first chosen" basis. All individuals who are eligible should be included as they are seen. | null | CONSECUTIVE SAMPLE |
C0026006 | Induction and quantitative measurement of chromosomal damage leading to the formation of micronuclei (MICRONUCLEI, CHROMOSOME-DEFECTIVE) in cells which have been exposed to genotoxic agents or IONIZING RADIATION. | Assays, Micronucleus|Test, Micronucleus|Tests, Micronucleus|Micronucleus Assay|Assay, Micronucleus|Micronucleus Assays|micronucleus test|Micronucleus Test|micronucleus assay | Micronucleus Tests |
C0751980 | A genotoxicological technique for measuring DNA damage in an individual cell using single-cell gel electrophoresis. Cell DNA fragments assume a "comet with tail" formation on electrophoresis and are detected with an image analysis system. Alkaline assay conditions facilitate sensitive detection of single-strand damage. | Gel Electrophoresis, Single-Cell|Assays, Comet|Assay, Comet|Comet Assay|Gel Electrophoreses, Single-Cell|Electrophoresis, Single-Cell Gel|Single Cell Gel Electrophoresis|Gel Electrophoresis, Single Cell|COMET|Comet Assays|Single-Cell Gel Electrophoresis|Electrophoreses, Single-Cell Gel|Single-Cell Gel Electrophoreses|Electrophoresis, Gel, Single-Cell | Comet Assay |
C0246421 | A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. | 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)|LETROZOLE|Letrozole-containing product|4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile|LTZ|Letrozole|letrozole|Product containing letrozole (medicinal product)|Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-|Letrozol|Letrozole (substance) | letrozole |
C0032099 | An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES. | Plants, Edible|foods plant|Food Plants|Plants, Food|Edible Plant|edible plants|Plant, Edible|Food Plant|Edible Plants|Plant, Food | Plants, Edible |
C0032099 | An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES. | Plants, Edible|foods plant|Food Plants|Plants, Food|Edible Plant|edible plants|Plant, Edible|Food Plant|Edible Plants|Plant, Food | Plants, Edible |
C0032099 | An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES. | Plants, Edible|foods plant|Food Plants|Plants, Food|Edible Plant|edible plants|Plant, Edible|Food Plant|Edible Plants|Plant, Food | Plants, Edible |
C0246421 | A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. | 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)|LETROZOLE|Letrozole-containing product|4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile|LTZ|Letrozole|letrozole|Product containing letrozole (medicinal product)|Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-|Letrozol|Letrozole (substance) | letrozole |
C0338484 | A migraine disorder characterized by individual and family history of aura that includes motor weakness. | Hemiplegic-ophthalmoplegic migraine|Familial hemiplegic migraine (disorder)|Familial hemiplegic migraine|Familial Hemiplegic Migraine|Familial Hemiplegic Migraines|Hemiplegic Migraine, Familial|Hemiplegic-Ophthalmoplegic Migraine|Mobius' syndrome I | Familial Hemiplegic Migraine |
C1412477 | null | APOC2 gene|apolipoprotein C2|APOC2|APOLIPOPROTEIN C-II | APOC2 gene |
C1412477 | null | APOC2 gene|apolipoprotein C2|APOC2|APOLIPOPROTEIN C-II | APOC2 gene |
C0019602 | An essential amino acid that is required for the production of HISTAMINE. | His|L-Histidine|HISTIDINE|(S)-2-Amino-3-(1H-imidazol-4-yl)propanoic acid|HIS|(S)-4-(2-Amino-2-carboxyethyl)imidazole|L-histidine|Histidina|(S)-alpha-Amino-1H-imidazole-4-propionic acid|L-(-)-histidine|(S)-a-Amino-1H-imidazole-4-propanoic acid|Histidine, L-isomer|L-Histidin|Histidine (substance)|l histidine|L-isomer Histidine|histidine|Histidine|(S)-alpha-amino-1H-Imidazole-4-propanoic acid|Histidine, L isomer|(S)-α-amino-1H-Imidazole-4-propanoic acid|l-Histidine|l-histidine | histidine |
C0026578 | The occurrence in an individual of two or more cell populations of different chromosomal constitutions, derived from a single ZYGOTE, as opposed to CHIMERISM in which the different cell populations are derived from more than one zygote. | MOSAICISM|Mosaicism|mosaicism | Mosaicism |
C0410528 | A general term describing features characterized by abnormal development of bones and connective tissues. [HPO:probinson] | dysplasia skeletal|skeletal dysplasia|OTHER SKELETAL DYSPLASIAS|Congenital skeletal dysplasia (disorder)|dysplasias skeletal|Osteodysplasia|Osteochondrodysplasia|Congenital skeletal dysplasia|Skeletal dysplasia | Skeletal dysplasia |
C0337527 | A male sibling. | brothers|Brother, NOS|brother|Brothers|Brother|Brother (person) | Brothers |
C1156814 | The chemical reactions and pathways involving glutamine, 2-amino-4-carbamoylbutanoic acid. [GOC:ai] | glutamine metabolism|glutamine metabolic process | glutamine metabolism |
C0917805 | null | Transient Cerebral Ischemia|Mini-Stroke|intermittent cerebral ischemia|CEREBRAL ISCHEMIA, TRANSIENT|Transient cerebral ischemia, NOS|Transient cerebral ischemia|Ischemias, Transient Cerebral|Transient Cerebral Ischemias|Unspecified transient cerebral ischemia|CEREBRAL ISCHEMIA, TRANSITORY|TIA|Ischemia, Transient Cerebral|Transient cerebral ischaemia, NOS|Ischemia, transient, cerebral|Cerebral Ischemias, Transient|transient cerebral ischemia|Cerebral Ischemia, Transient|Mini-stroke | Transient Cerebral Ischemia |
C0598940 | null | neuron loss | Loss of neurons |
C0969698 | Nitrogenous products of NITRIC OXIDE synthases, ranging from NITRIC OXIDE to NITRATES. These reactive nitrogen intermediates also include the inorganic PEROXYNITROUS ACID and the organic S-NITROSOTHIOLS. | Nitrogen Species, Reactive|Species, Reactive Nitrogen | Reactive Nitrogen Species |
C0917798 | Diminished or absent blood supply to the brain caused by obstruction (thrombosis or embolism) of an artery resulting in neurologic damage. | Ischemia cerebrovascular|Cerebral ischaemia, NOS|Cerebral ischemia|Cerebral ischemia (disorder)|Cerebral Ischemia|Cerebral Ischemias|cerebral ischaemia|cerebral vascular insufficiency|ischemia cerebral|Ischemia, Cerebral|cerebral ischemia|Cerebrovascular insufficiency syndrome|Ischemias, Cerebral|cerebrovascular ischaemia|Cerebral ischaemia|Cerebrovascular ischemia|Cerebral ischemia, NOS|ISCHEMIA CEREBRAL|Cerebrovascular Ischemia|ISCHEMIA CEREBROVASCULAR|CEREBRAL VASCULAR INSUFFICIENCY|CEREBRAL ISCHEMIA | Cerebral Ischemia |
C0061467 | family of potassium-dependent acidic amino acid transporters that demonstrate a high affinity for glutamate and aspartate; several variants of this system are found in neuronal tissue. | glutamate transporter|Glutamate Translocase|Transport Glycoprotein, Glutamate|Glutamate Transporter|Glutamate Transport Glycoprotein | Glutamate Transporter |
C0596902 | Membrane proteins whose primary function is to facilitate the transport of molecules across a biological membrane. Included in this broad category are proteins involved in active transport (BIOLOGICAL TRANSPORT, ACTIVE), facilitated transport and ION CHANNELS. | membrane transport protein|Transport Proteins, Membrane|transporter|transporters|membrane transport proteins|Membrane Transport Proteins|membrane transporter|Membrane Transporters|Transporters, Membrane | Membrane Transport Proteins |
C0031923 | A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. | Pilocarpine (substance)|Pilocarpina|pilocarpine|2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S-cis)-|Product containing pilocarpine (medicinal product)|Pilocarpine|PILOCARPINE|Pilocarpine-containing product | pilocarpine |
C0917714 | Region in the ventral TELENCEPHALON located anterior to the OPTIC CHIASM, posterior to the OLFACTORY PEDUNCLE, rostral to the PIRIFORM AREA and ventral to the NUCLEUS ACCUMBENS. | Tubercle, Olfactory|Anterior perforated area|Tuberculum Olfactorium|Posterior Olfactory Lobule|Anterior Perforated Substance|Substantia perforata rostralis|Structure of anterior perforated substance|Perforated Substances, Anterior|Tuberculum Olfactoriums|anterior perforated substance|Eminentia parolfactoria|Area olfactoria (Mai)|Olfactoriums, Tuberculum|Anterior perforated substance|Anterior Perforated Substances|Tubercles, Olfactory|Substances, Anterior Perforated|Olfactorium, Tuberculum|Olfactory Tubercles|Olfactory tubercle|Area olfactoria (Shantha)|Perforated Substance, Anterior|Anterior perforated space|Olfactory Tubercle|Tuberculum olfactorium|Substantia perforata anterior|Olfactory area (Mai)|Structure of anterior perforated substance (body structure)|Anterior Perforated Space|Substance, Anterior Perforated | Olfactory tubercle |
C0244104 | A 2-oxo monocarboxylic acid anion that is the conjugate base of pyruvic acid, which is an important metabolic product for energy-producing biochemical pathways. Pyruvate is the final product of glycolysis and, when hypoxic conditions arise, can be metabolized anaerobically to form lactate. This chemical is a precursor of both acetyl-coenzyme A and oxaloacetate, which are involved in the citric acid cycle. Additionally, oxaloacetate is a substrate in the gluconeogenesis pathway. | Pyruvate|pyruvate|2-Oxopropanoate|Propanoic Acid, 2-Oxo-, Ion(1-)|Pyruvate (substance) | pyruvate |
C0908044 | null | DL-TBOA|TBOA | DL-threo-beta-benzyloxyaspartate |
C0054275 | null | butyl chloride|1-chlorobutane|Butyl chloride|1-chlorobutane (substance)|Butyl Chloride|BUTYL CHLORIDE | butyl chloride |
C0058325 | null | (Z,Z)-4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxo-9-octadecenyl)oxy)-3,5,9-trioxa-4-phosphaheptacos-18-en-1-aminium, hydroxide, inner salt, 4-oxide|dielaidoylphosphatidylcholine|dioleoyl phosphatidylcholine|dioleoylphosphatidylcholine|DOPC|1,2-dioleoylglycerophosphocholine|1,2-dioleoyl glycerophosphocholine|1,2-DOCPC|dioleylphosphatidylcholine|dioleoylphosphatidylcholine, DL- | 1,2-oleoylphosphatidylcholine |
C1100347 | null | null | cavitand |
C0076543 | null | Threitol|Threitol (substance) | threitol |
C0034149 | Functionally and structurally differentiated, purple-pigmented regions of the cytoplasmic membrane of some strains of Halobacterium halobium. The membrane develops under anaerobic conditions and is made almost entirely of the purple pigment BACTERIORHODOPSINS. (From Singleton & Sainsbury Dictionary of Microbiology and Molecular Biology, 2d ed) | Membrane, Purple|bacterial purple membrane|Purple Membranes|Membranes, Purple | Purple Membrane |
C0002170 | Absence of hair from areas where it is normally present. | Loss of hair (finding)|falling hairs|Alopecia Areata|baldness|ALOPECIA|Alopecia|Losses, Hair|loss of hair|Loss Of Hair|BALDNESS|Alopecia, unspecified|Alopecia (disorder)|alopecia disorders|Hair loss|bald|Loss, Hair|Alopecia, NOS|Loss of hair|Falling hair|HAIR THINNING|Hair Losses|thinning hair|falls hair|Alopecias|Hair loss disorder|Hair absent|Baldness|alopecia|Thinning hair|alopecias|hair falling|hair loss|Bald|Hair Loss|falling hair|HAIR LOSS | Alopecia |
C0301896 | Any of the processes involved in cytolysis of a target cell by effector lymphocytes, such as cytotoxic T lymphocytes or NK cells; it may be antibody-dependent or independent. | Cell-mediated lympholysis, function|Cell-Mediated Cytotoxicity|Lymphocytotoxicity|Cell-Mediated Cytolysis|Lymphocyte Cytotoxicity|Cytotoxicity, Immunologic|Cell-mediated cytolysis|cell mediated cytotoxicity|Cell mediated cytolysis|Cell-mediated cytotoxicity|lymphocytotoxicity|Cell-mediated lympholysis, function (observable entity)|Cellular Cytotoxicity|Cell-Mediated Lympholysis|Lympholysis, cell mediated|Cell-mediated lympholysis | Cell-Mediated Cytolysis |
C0037506 | An anionic surfactant, usually a mixture of sodium alkyl sulfates, mainly the lauryl; lowers surface tension of aqueous solutions; used as fat emulsifier, wetting agent, detergent in cosmetics, pharmaceuticals and toothpastes; also as research tool in protein biochemistry. | Sulfuric acid monododecyl ester sodium salt|sodium dodecyl sulfate|SODIUM lauryl SULFATE|Laurylsiran sodny|Sodium dodecyl sulfate|sodium lauryl sulfate|SLS|Sodium lauryl sulfate|Sulfate, Sodium Lauryl|Sodium lauryl sulfate (substance)|Lauryl Sulfate, Sodium|Dodecyl Sulfate, Sodium|NaDS|Sodium laurilsulfate|SDS|Sodium dodecylsulfate|Sulfate, Sodium Dodecyl|Sodium lauryl Sulfate|Natrium laurylsulfuricum|SODIUM LAURYL SULFATE|Sodium Lauryl Sulfate|Sodium dodecyl sulphate|Sodium lauryl sulphate|Sodium Dodecyl Sulfate | sodium dodecyl sulfate |
C0125650 | null | polyfructose | levan |
C0125650 | null | polyfructose | levan |
C0013595 | A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed). | eczema|Eczemas|Dermatitis, Eczematous|ECZEMA|Atopic Dermatitis|ECZEMATOUS DERMATITIS|Dermatitis, eczematous|Eczematous dermatitis, NOS|Unclassifiable eczema (disorder)|DERMATITIS ECZEMATOID|Eczematous Dermatitides|eczemas|ECZEMATOUS SKIN LESIONS|Eczema NOS|Dermatitides, Eczematous|Eczematoid dermatitis|Eczematous Dermatitis|Eczema (disorder)|eczematous rash|Eczematous dermatitis|eczema nos|eczematoid dermatitis|Unclassifiable eczema|eczematous dermatitis|Eczema, NOS|Eczema | Eczema |
C0440931 | null | Forearm flap (substance) | Forearm flap |
C0016129 | Four or five slender jointed digits in humans and primates, attached to each HAND. | Fingers|fingers|Finger|Finger structure|Digit of hand|Finger structure (body structure)|Digit of hand structure|Finger, NOS|finger|FINGER|digit hand|Digit of hand structure (body structure)|Digitus manus|Digiti manus|Set of fingers|Set of digits of hand|hand digit|anatomy finger|Foredigit, NOS|Fingers including thumb|Digits of hand|digits hand|Fingers set | Fingers |
C1444716 | null | donor sites|donor site|Donor site (body structure)|Donor site|Donor site, NOS|Donor site (attribute) | Donor site |
C0030580 | The largest of the three pairs of SALIVARY GLANDS. They lie on the sides of the FACE immediately below and in front of the EAR. | parotid gland|Glands, Parotid|Parotid glands|PAROTID GLANDS|PAROTID GLAND|Glandula parotidea|Parotid|Parotid gland, NOS|Parotid gland structure (body structure)|Parotid Gland|gland parotid|glands parotid|Parotid Glands|Parotid gland|parotids|parotid|GLAND, SALIVARY, PAROTID|Parotid, NOS|Parotid structure|parotid glands|Gland, Parotid|Parotid gland structure | Parotid Gland |
C0079611 | Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. | Immunophenotype|immunophenotyping|Immunotype|Immunophenotyping (procedure)|Immunologic Subtypings|Immunophenotypings|Immunologic Subtyping|immunophenotype|Immunophenotyping|Subtyping, Immunologic|Subtypings, Immunologic | Immunophenotyping |
C0040408 | A muscular organ in the mouth that is covered with pink tissue called mucosa, tiny bumps called papillae, and thousands of taste buds. The tongue is anchored to the mouth and is vital for chewing, swallowing, and for speech. | Lingual|lingual|Tongue structure|Tongue structure (body structure)|tongue|tongues|tongue structure|Tongues|Lingua|Tongue|Linguo-|TONGUE|Tongue, NOS | Tongue |
C0038556 | One of two salivary glands in the neck, located in the space bound by the two bellies of the digastric muscle and the angle of the mandible. It discharges through the submandibular duct. The secretory units are predominantly serous although a few mucous alveoli, some with serous demilunes, occur. (Stedman, 25th ed) | Gland, Submandibular|glands submandibular|Submandibular Gland|submaxillary gland|Submandibular gland|Gland, Submaxillary|submandibular glands|Glands, Submandibular|submandibular gland|Submandibular Glands|Submandibular salivary apparatus (body structure)|Submaxillary gland, NOS|gland submaxillary|Glandula submandibularis|Glands, Submaxillary|GLAND, SALIVARY, SUBMANDIBULAR|Submandibular salivary gland structure (body structure)|gland submandibular|Submaxillary gland|Submandibular salivary apparatus|Submaxillary (Submandibular) Glands|Submandibular salivary gland structure|Submaxillary Gland|Gland, Salivary, Mandibular|Submandibular salivary structure|SUBMANDIBULAR GLAND|SUBMAXILLARY GLANDS|Submaxillary Glands | Submandibular gland |
C0032112 | Specialized forms of antibody-producing B-LYMPHOCYTES. They synthesize and secrete immunoglobulin. They are found only in lymphoid organs and at sites of immune responses and normally do not circulate in the blood or lymph. (Rosen et al., Dictionary of Immunology, 1989, p169 & Abbas et al., Cellular and Molecular Immunology, 2d ed, p20) | Cell, Plasma|Plasmocyte|Plasmacytic cell|plasmocytes|plasma cells|Plasmacytic|plasmacytic|Plasmocytic|Cells, Plasma|plasmacyte|Plasma cell (cell)|Plasma cell, NOS|plasma cell|Plasma cell|Plasma Cells|Blood plasma cell|cells plasma|Plasmacyte|Plasma cells|plasmocyte|Plasmacytes|Plasma Cell|cell plasma | Plasma Cells |
C0189722 | null | Arterial ligation, NOS|Ligation of artery, NOS|Arterial ligation|arterial ligation|Ligation of artery (procedure)|artery ligation | Ligation of artery |
C1261150 | null | Cytology examination - general (procedure)|Cytology - general|Cytology examination - general | Cytology examination |
C0341034 | null | impacted molar|impact molar|impacted molars|Impacted molars (disorder) | Impacted molars |
C0333361 | A morphologic finding indicating the presence of neutrophils and/or eosinophils in a tissue sample. | ACUTE INFLAMMATIONS|Acute Inflammations|Inflammation, acute|Acute inflammation (morphologic abnormality)|inflammation acute|Acute inflammatory infiltration|Acute inflammatory cell infiltration|Polymorphonuclear leukocyte infiltration|Polymorphonuclear leukocyte infiltration, NOS|Acute inflammatory reaction, NOS|Acute inflammatory infiltration, NOS|Active inflammation|Active inflammation, NOS|Acute inflammation, NOS|Acute inflammatory reaction|Acute inflammatory cell infiltration, NOS|Neutrophilic infiltration, NOS|Neutrophilic infiltration|Acute Inflammatory Infiltrate|Acute Inflammation|Inflammatory cell infiltration, acute|acute inflammation|Polymorphonuclear leucocyte infiltration | Acute inflammation |
C0332469 | A long narrow slit or groove that divides an organ into lobes. | Fissure|Fissured|fissur|Fissures|Fissure, NOS|fissures|Fissured structure|fissuring|fissured|Fissure (morphologic abnormality)|fissure|Fissured (qualifier value)|long narrow cracks|FISSURE | Fissure |
C0440811 | null | Mucoperiosteum|Periosteomucosal graft (substance) | Periosteomucosal graft |
C0025962 | The circulation of the BLOOD through the MICROVASCULAR NETWORK. | Microcirculation|microcirculation | Microcirculation |
C1527336 | Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. | Sjogren's syndrome|Sjogren's disease|Sjögren Syndrome|sjogren syndrome|syndrome sjogrens|Sjogrens Syndrome|Syndrome, Sjogren's|Sjögren's syndrome (disorder)|SYNDROME SJOGREN'S|Sjögren's syndrome|GOUGEROUT-SJOEGREN SYNDROME|sjogren's disease|SJOEGREN SYNDROME|sjogren's syndromes|Sjogren syndrome|Sjögren's disease|sjogrens syndrome|SJOGRENS SYNDROME|SJOGREN'S SYNDROME|Sjogren's Syndrome|sjoegren's syndrome|SJOGREN SYNDROME|sjogrens's syndrome|Sjogrens syndrome|syndrome sjogren|Sjögren syndrome|sjogren's syndrome|Sjogren Syndrome | Sjogren's Syndrome |
C0266929 | Chronic inflammation and loss of PERIODONTIUM that is associated with the amount of DENTAL PLAQUE or DENTAL CALCULUS present. Chronic periodontitis occurs mostly in adults and was called adult periodontitis, but this disease can appear in young people. | PERIODONTITIS, ADULT|Adult periodontitis (disorder)|Adult Periodontitides|Periodontitides, Chronic|PERIODONTITIS, CHRONIC|Chronic periodontitis|Chronic pericementitis|Chronic periodontal disease|Adult periodontitis|Periodontitis, Chronic|Chronic periodontitis, unspecified|Periodontitides, Adult|Periodontitis, Adult|chronic periodontitis|Chronic Periodontitis|Adult Periodontitis|Chronic Periodontitides|Adult-onset periodontitis|Chronic periodontitis (disorder) | Chronic Periodontitis |
C0017562 | Oral tissue surrounding and attached to TEETH. | gingiv(o)-|Gingival structure (body structure)|Gum, NOS|Gums|GINGIVA|gingiva|Gingival|Gingiva, NOS|gum|gums|gingi(o)-|Gingiva|Gingival structure|Gum|gingival|Periodontium protectionis | Gingiva |
C0021988 | Complexes of iodine and non-ionic SURFACE-ACTIVE AGENTS acting as carrier and solubilizing agent for the iodine in water. Iodophors usually enhance bactericidal activity of iodine, reduce vapor pressure and odor, minimize staining, and allow wide dilution with water. (From Merck Index, 11th ed) | Tamed Iodine|iodophor|Iodine, Tamed|Iodophors|iodophors | iodophors |
C0460004 | For oncology, an area of the body generally construed to comprise the base of skull and facial bones, sinuses, orbits, salivary glands, oral cavity, oropharynx, larynx, thyroid, facial and neck musculature and lymph nodes draining these areas. | Head and neck|neck head|HEAD AND NECK: GENERAL TERMS|H and N|Head and neck structure|Head and neck region, NOS|head neck|Craniocervical region|Structure of head and/or neck|Structure of head and/or neck (body structure)|Head and Neck|Head and neck, NOS|head and neck|HEAD AND NECK | Head and neck structure |
C0031028 | Diseases of the PERIAPICAL TISSUE surrounding the root of the tooth, which is distinguished from DENTAL PULP DISEASES inside the TOOTH ROOT. | Diseases, Periapical|Disorder of periapical tissues of tooth|Periapical diseases|Disease of periapical tissues of tooth, NOS|Periradicular disease|Disorder of periapical tissues of tooth (disorder)|Disease, Periapical|Periapical Disease|periapical disease | Periapical Diseases |
C0011461 | A partial denture attached to prepared natural teeth, roots, or implants by cementation. | Dentures, Fixed Partial|bridge fixed|fixed partial denture|Bridge, Fixed|fixed bridge|Fixed Bridges|fixed partial dentures|Fixed Partial Denture|Fixed Partial Dentures|Partial Dentures, Fixed|Bridges, Fixed|denture fixed partial|Denture, Fixed Partial|Fixed Bridge|fixed bridges|Partial Denture, Fixed | Denture, Partial, Fixed |
C0597134 | see RTs for specific organisms. | oral bacteria|flora oral|bacteria oral|oral flora | oral bacteria |
C0038409 | A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque. | Streptococcus mutans|STREPTOCOCCUS MUTANS|mutan streptococcus|Streptococcus mutans (organism)|Streptococcus mutans aggregate|mutans streptococcus|streptococcus mutans | Streptococcus mutans |
C0023946 | Movement or the ability to move from one place or another. It can refer to humans, vertebrate or invertebrate animals, and microorganisms. | Activities, Locomotor|Locomotor Activity|Locomotor Activities|locomotion|Locomotion|Activity, Locomotor | Locomotion |
C0036019 | An abrupt voluntary shift in ocular fixation from one point to another, as occurs in reading. | Pursuits, Saccadic|Saccade|Pursuit, Saccadic|Saccadic pursuits|saccade|Saccadic Pursuit|saccadic eye movements|Saccadic Eye Movements|saccadic eye movement|Saccadic pursuit|Saccadic eye movements|eye movement saccadic|Eye Movements, Saccadic|saccades|Eye Movement, Saccadic|Saccadic eye movement (observable entity)|Saccadic Eye Movement|saccadic pursuit|Movements, Saccadic Eye|Saccadic Pursuits|Movement, Saccadic Eye|Saccadic eye movement | Saccades |
C0007789 | A heterogeneous group of nonprogressive motor disorders caused by chronic brain injuries that originate in the prenatal period, perinatal period, or first few years of life. The four major subtypes are spastic, athetoid, ataxic, and mixed cerebral palsy, with spastic forms being the most common. The motor disorder may range from difficulties with fine motor control to severe spasticity (see MUSCLE SPASTICITY) in all limbs. Spastic diplegia (Little disease) is the most common subtype, and is characterized by spasticity that is more prominent in the legs than in the arms. Pathologically, this condition may be associated with LEUKOMALACIA, PERIVENTRICULAR. (From Dev Med Child Neurol 1998 Aug;40(8):520-7) | Cerebral palsy|CP|Cerebral palsy NOS|Cerebral palsy (CP)|CEREBRAL PALSY|cerebral palsy|Cerebral palsied|cerebral paralysis|PALSY CEREBRAL|Cerebral palsy (disorder)|CP (Cerebral Palsy)|Cerebral Palsy|Congenital cerebral palsy|Cerebral palsy, NOS|PALSY, CEREBRAL|Cerebral paralysis|CP - Cerebral palsy|Infantile cerebral palsy|cerebral palsy unspecified | Cerebral Palsy |
C0220843 | The ability to hold or grasp. | Grasps|grasp|Grip|grip|Grips|Grasp|grips|grasps | grasp |
C1517714 | Anterior pituitary cells that produce PROLACTIN. | Prolactin Cell|Pituitary mammotropic cell (cell)|Lactotroph|Lactotrope Cell|PRL Cell|Mammotroph|Prolactin-Secreting Cells, Pituitary|Pituitary Prolactin-Secreting Cell|Pituitary Prolactin Cell|Prolactin-Secreting Cell, Pituitary|Prolactin Cells, Pituitary|Pituitary Prolactin-Secreting Cells|Pituitary Prolactin Cells|Pituitary mammotropic cell|lactotroph|Lactotrope cell|Lactotroph Cell|Prolactin secreting cell|Pituitary Prolactin Secreting Cells|Prolactin Cell, Pituitary|Mammotrope | Lactotrophs |
C0014230 | Enzymes that catalyze the hydrolysis of the internal bonds and thereby the formation of polynucleotides or oligonucleotides from ribo- or deoxyribonucleotide chains. EC 3.1.-. | endonucleases|Endonucleases|endonuclease | endonuclease |
C0682634 | null | leukocyte precursor | Leukocyte precursor |
C1157894 | The cellular DNA metabolic process resulting in the breakdown of DNA, deoxyribonucleic acid, one of the two main types of nucleic acid, consisting of a long unbranched macromolecule formed from one or two strands of linked deoxyribonucleotides, the 3'-phosphate group of each constituent deoxyribonucleotide being joined in 3',5'-phosphodiester linkage to the 5'-hydroxyl group of the deoxyribose moiety of the next one. [GOC:go_curators, ISBN:0198506732] | DNA breakdown|DNA degradation|DNA catabolism | DNA catabolic process |
C0032099 | An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES. | Plants, Edible|foods plant|Food Plants|Plants, Food|Edible Plant|edible plants|Plant, Edible|Food Plant|Edible Plants|Plant, Food | Plants, Edible |
C0032099 | An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES. | Plants, Edible|foods plant|Food Plants|Plants, Food|Edible Plant|edible plants|Plant, Edible|Food Plant|Edible Plants|Plant, Food | Plants, Edible |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.